Severe combined immunodeficiency caused by inositol-trisphosphate 3-kinase B (ITPKB) deficiency
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 145 (6), 1696-1699.e6
- https://doi.org/10.1016/j.jaci.2020.01.014
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Regulation of Hematopoietic Cell Development and Function Through PhosphoinositidesFrontiers in Immunology, 2018
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsAmerican Journal of Human Genetics, 2016
- Common variable immunodeficiency associated with microdeletion of chromosome 1q42.1‐q42.3 and inositol 1,4,5‐trisphosphate kinase B (ITPKB) deficiencyClinical & Translational Immunology, 2016
- IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in miceBlood, 2015
- A general framework for estimating the relative pathogenicity of human genetic variantsNature Genetics, 2014
- In Silico Modeling of Itk Activation Kinetics in Thymocytes Suggests Competing Positive and Negative IP4 Mediated Feedbacks Increase RobustnessPLOS ONE, 2013
- Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activationNature Immunology, 2007
- Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patientsImmunological Reviews, 2005
- Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activityProceedings of the National Academy of Sciences of the United States of America, 2004
- Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte developmentNature Immunology, 2003